NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
14 March 2025
| Name: | CCP TECHNOLOGIES LIMITED (CT1) (This company subsequently changed its name to CONSTELLATION TECHNOLOGIES LIMITED. You should refer to that name for Status.) | ||||||||||||
| Date of Listing: | 08 October 1987 | ||||||||||||
| Subsequent Names: |
| ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to CONSTELLATION TECHNOLOGIES LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to CONSTELLATION TECHNOLOGIES LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now CONSTELLATION TECHNOLOGIES LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| CONSTELLATION TECHNOLOGIES LIMITED | 04/06/2020 | |
| CCP TECHNOLOGIES LIMITED | 23/11/2016 | 04/06/2020 |
| AGENIX LIMITED | 22/06/2001 | 23/11/2016 |
| BIOTECH INTERNATIONAL LIMITED | 06/07/1989 | 22/06/2001 |
| UNIFUND AUSTRALIA LIMITED | 06/07/1989 |
Advanced Share Registry Services
110 Stirling Hwy, Nedlands WA 6009
Tel : +61 8 9389 8033
Fax : +61 8 9262 3723
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Constellation Technologies Limited | 04/06/2020 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately following the release by CT1 of an announcement regarding its non-renounceable entitlement issue. | 18/10/2019 |
The company announces a one for one non-renounceable pro rata entitlement issue. One free attaching option for each share applied for will be granted. The rights issue will be availalbe to holders of shaers in the company with a registered address in Australia and New Zealand as at 24 October 2019. | 18/10/2019 |
The securities of CCP Technologies Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of CT1, pending the release of an announcement regarding the final execution of agreements relating to the entitlement offer. | 17/10/2019 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately following the release by CT1 of an announcement advising that it has withdrawn from discussions in relation to a potential acquisition. | 24/07/2019 |
The company has withdrawn from the potential corporate transaction discussions. There were and are no binding commercial terms in place in respect to the potential transaction. The company will focus on other commercial and potential corporate opportunities. | 24/07/2019 |
The company has received commitments from investors to raise $576,592 by issue of 44,353,252 new ordinary shares at $0.013 per share. The shares will be issued from the company's remaining placement capacity under Listing Rule 7.1. The company seeks an extension of the suspension of its securities in order to further progress the discussions in connection with the potential corporate transaction and to subsequently finalise an announcement in relation to those discussions. The company expects to make an announcement regarding this by the commencement of trade on 24 July 2019. | 19/07/2019 |
The securities of CCP Technologies Limited will be suspended from quotation immediately under ListingbRule 17.2, at the request of CT1, pending the release of an announcement regarding proposed capital raising and the potential corporate transaction. | 17/07/2019 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately, following release of an announcement of a proposed capital raising and the Company's response to an ASX Query. | 17/07/2018 |
The company issues a response to an ASX query. | 17/07/2018 |
The company has received commitments from strategic investors to raise $861,247 (before costs) by issue of 43,062,350 new ordinary shares at $0.02 per share. Each subscriber in the placement will also receive a two-year unlisted option, for each share issued, with an exercise price of $0.03, subject to shareholder approval at the Company's 2018 Annual General Meeting. CCP welcomes Penta Global Blockchain Foundation and First Growth Funds to the register. The company also announces the acceleration of CCP's blockchain initiatives. | 17/07/2018 |
The securities of CCP Technologies Limited will be suspended from quotation immediately, in accordance with Listing Rule 17.3, pending the release of a satisfactory announcement in relation to the Company's proposed capital raising. | 13/07/2018 |
name changed from Agenix Limited | 23/11/2016 |
name changed to Constellation Technologies Limited | 04/06/2020 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately following the release by CT1 of an announcement regarding its non-renounceable entitlement issue. | 18/10/2019 |
The company announces a one for one non-renounceable pro rata entitlement issue. One free attaching option for each share applied for will be granted. The rights issue will be availalbe to holders of shaers in the company with a registered address in Australia and New Zealand as at 24 October 2019. | 18/10/2019 |
The securities of CCP Technologies Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of CT1, pending the release of an announcement regarding the final execution of agreements relating to the entitlement offer. | 17/10/2019 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately following the release by CT1 of an announcement advising that it has withdrawn from discussions in relation to a potential acquisition. | 24/07/2019 |
The company has withdrawn from the potential corporate transaction discussions. There were and are no binding commercial terms in place in respect to the potential transaction. The company will focus on other commercial and potential corporate opportunities. | 24/07/2019 |
The company has received commitments from investors to raise $576,592 by issue of 44,353,252 new ordinary shares at $0.013 per share. The shares will be issued from the company's remaining placement capacity under Listing Rule 7.1. The company seeks an extension of the suspension of its securities in order to further progress the discussions in connection with the potential corporate transaction and to subsequently finalise an announcement in relation to those discussions. The company expects to make an announcement regarding this by the commencement of trade on 24 July 2019. | 19/07/2019 |
The securities of CCP Technologies Limited will be suspended from quotation immediately under ListingbRule 17.2, at the request of CT1, pending the release of an announcement regarding proposed capital raising and the potential corporate transaction. | 17/07/2019 |
The suspension of trading in the securities of CCP Technologies Limited will be lifted immediately, following release of an announcement of a proposed capital raising and the Company's response to an ASX Query. | 17/07/2018 |
The company issues a response to an ASX query. | 17/07/2018 |
The company has received commitments from strategic investors to raise $861,247 (before costs) by issue of 43,062,350 new ordinary shares at $0.02 per share. Each subscriber in the placement will also receive a two-year unlisted option, for each share issued, with an exercise price of $0.03, subject to shareholder approval at the Company's 2018 Annual General Meeting. CCP welcomes Penta Global Blockchain Foundation and First Growth Funds to the register. The company also announces the acceleration of CCP's blockchain initiatives. | 17/07/2018 |
The securities of CCP Technologies Limited will be suspended from quotation immediately, in accordance with Listing Rule 17.3, pending the release of a satisfactory announcement in relation to the Company's proposed capital raising. | 13/07/2018 |
name changed from Agenix Limited | 23/11/2016 |
Your browser may reflect a date of printing in American format.
The global cardiovascular monitoring and diagnostic devices market to reach nearly US$ 8 Billion by 2021, growing at a CAGR of 9.0% from 2017 to 2021. Market by device or product type (ECG systems, resting ECG systems, stress ECG systems, cardiovascular diagnostic catheters, event monitors, Holter monitors, implantable loop recorders, ECG management systems). Major players are Boston Scientific Corporation, Covidien plc, FUKUDA DENSHI Co., Ltd., GE Healthcare, Johnson & Johnson, Medtronic, Inc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Sorin Group, Spacelabs Healthcare, St. Jude Medical, Inc and Welch Allyn, Inc. https://www.ihealthcareanalyst.com/report/cardiovascular-monitoring-diagnostic-devices-market/ | 27/12/2017 00:17:24 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 18/10/2019 | Anoosh Manzoori | 1,000,000 | $0.012 | $12,000 |
| 19/09/2017 | Adam Gallagher | 395,000 | $0.019 | $7,632 |
| 07/09/2017 | Anthony Rowley | 85,000 | $0.024 | $2,037 |
| 27/04/2017 | Michael White | 50,000 | $0.022 | $1,122 |
| 21/04/2017 | Anthony Rowley | 868,500 | $0.018 | $16,002 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Leath Nicholson | Non Exec Chairman, Independent Director | 14/10/2016 |
| Terri Bakos | CFO, Company Secretary | 01/01/2019 |
| Anoosh Manzoori | Independent Director | 14/10/2016 |
| Adam Gallagher | Director, CEO | 01/06/2015 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Phillip Hains | CFO | 09/11/2017 | 17/12/2019 |
| Anthony Rowley | Director, COO | 07/09/2016 | 08/02/2019 |
| Michael White | Director, CEO | 07/09/2016 | 08/02/2019 |
| Garry Taylor | CFO | 31/03/2011 | 09/11/2017 |
| Chris McNamara | Non Exec Director | 01/02/2008 | 06/03/2017 |
| Craig Chapman | Non Exec Director | 21/05/2013 | 18/11/2016 |
| Nicholas Weston | Executive Chairman, CEO | 22/08/2008 | 01/06/2015 |
| Anthony Lee | Non Exec Director | 27/08/2007 | 12/11/2014 |
| Stephen Phua | CEO | 04/01/2010 | |
| Jonathan Zhang | Non Exec Director | 30/10/2009 | |
| Gordon Crosbie-Walsh | Non Exec Director | 01/02/2008 | 12/08/2008 |
| James Liu | Non Exec Director | 12/08/2008 | |
| Ravindran Govindan | Non Exec Chairman | 13/06/2000 | 08/08/2008 |
| Neil Leggett | Company Secretary | 01/05/2003 | 29/05/2008 |
| Andre Lamotte | Non Exec Director | 28/09/2005 | 09/05/2008 |
| Karl Schlobohm | Company Secretary | 16/12/2005 | 31/01/2008 |
| Gim-Choon Ang | Non Exec Director | 31/08/2007 | |
| Fong Wong | Non Exec Director | 11/08/2000 | 12/12/2006 |
| Myles Davey | Non Exec Director | 20/11/2006 | |
| Donald Home | CEO | 15/12/2005 | |
| Katherine Woodthorpe | Non Exec Director | 21/06/2001 | 08/05/2003 |
| Mark Carnegie | Non Exec Director | 17/11/2000 | 10/12/2002 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
